Bright Green announces federal registration, license approval with U.S. DEA

Bright Green Corporation confirmed the registration of its federal license with the U.S. Drug Enforcement Administration. Bright Green’s DEA registration confers the necessary authorization to operate and create revenue under U.S. federal law, as well as qualifying the company to export into countries with equivalent recognition of cannabis and cannabis-related products for pharmaceutical purposes. This registration follows completion of a significant process, which culminated with the agency’s site visits and inspections of Bright Green’s agricultural complex in Grants, New Mexico, with the final inspection on March 22, 2023. This process included an audit of both our manufacturing and extraction facilities, as well as the greenhouse currently under construction. The Company successfully demonstrated to the DEA its compliance with federal regulations covering the cultivation of marijuana for research purposes in compliance with the Controlled Substances Act and international treaty obligations. Bright Green is now federally registered and well-positioned in this emerging market to generate significant revenue on a global basis and is now fully armed to commence revenue generation and plans to bring disruptive activities to the worldwide Medical Cannabis Markets.